← Open Payments lookup

SARAH LOUDERMILK: Open Payments

NPI 1295156917 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,879 in 94 payments from 10 companies in 2025. Trend: 2023 $2,369 · 2024 $2,288 · 2025 $1,879

Food & beverage: $1,695Education: $184
CompanyPaymentsAmount
ABBVIE INC.38$606
Janssen Biotech, Inc.23$549
Takeda Pharmaceuticals U.S.A., Inc.11$223
Ferring Pharmaceuticals Inc.4$105
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$99
Aimmune Therapeutics, Inc.5$98
Phathom Pharmaceuticals, Inc.4$80
Regeneron Healthcare Solutions, Inc.3$77
Braintree Laboratories, Inc.1$24
VIVUS LLC1$17

Products named: TREMFYA, RINVOQ, ENTYVIO, LINZESS, SKYRIZI, REBYOTA, ZENPEP, VOQUEZNA.

Industry payments across TX — which companies pay providers there.